ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $632,645 | -48.8% | 17,746 | -33.8% | 0.00% | 0.0% |
| Q2 2023 | $1,236,330 | +28.1% | 26,801 | +11.4% | 0.00% | 0.0% |
| Q1 2023 | $965,127 | +5.0% | 24,068 | +21.3% | 0.00% | 0.0% |
| Q4 2022 | $918,909 | +104.7% | 19,834 | +82.9% | 0.00% | – |
| Q3 2022 | $449,000 | -44.3% | 10,844 | -19.7% | 0.00% | -100.0% |
| Q2 2022 | $806,000 | -20.0% | 13,506 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $1,008,000 | +26.0% | 13,882 | +46.0% | 0.00% | 0.0% |
| Q4 2021 | $800,000 | -9.8% | 9,509 | -3.3% | 0.00% | 0.0% |
| Q3 2021 | $887,000 | -1.4% | 9,838 | +4.2% | 0.00% | 0.0% |
| Q2 2021 | $900,000 | -49.7% | 9,441 | -39.9% | 0.00% | -50.0% |
| Q1 2021 | $1,790,000 | +32.9% | 15,718 | +61.6% | 0.00% | +100.0% |
| Q4 2020 | $1,347,000 | +167.8% | 9,728 | +59.1% | 0.00% | 0.0% |
| Q3 2020 | $503,000 | +10.1% | 6,116 | +4.8% | 0.00% | 0.0% |
| Q2 2020 | $457,000 | +71.2% | 5,838 | +11.6% | 0.00% | – |
| Q1 2018 | $267,000 | -9.5% | 5,231 | -17.9% | 0.00% | -100.0% |
| Q4 2017 | $295,000 | -23.6% | 6,371 | -12.1% | 0.00% | 0.0% |
| Q3 2017 | $386,000 | -12.7% | 7,248 | +1.9% | 0.00% | 0.0% |
| Q2 2017 | $442,000 | +23.1% | 7,110 | +34.2% | 0.00% | 0.0% |
| Q1 2017 | $359,000 | -6.8% | 5,298 | -3.2% | 0.00% | 0.0% |
| Q4 2016 | $385,000 | -54.3% | 5,475 | -53.9% | 0.00% | -50.0% |
| Q3 2016 | $843,000 | +263.4% | 11,878 | +150.1% | 0.00% | +100.0% |
| Q2 2016 | $232,000 | -66.7% | 4,749 | -56.8% | 0.00% | -50.0% |
| Q1 2016 | $696,000 | – | 10,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |